Many of the world’s most threatening viruses continue to evolve faster than new medicines can be developed.
Instead of chasing viruses as they evolve, we are working to get ahead of them. To do this, we built Octavia™.
Octavia is our technology platform.
Octavia generates maps of existing and potential viral variants based on their ability to bind human cells and evade antibodies. Using these maps, we can define the combination of antibodies (antibody repertoire) that would best protect us against current and future threats and fill gaps in our defenses with new medicines – specifically, vaccines and antibodies.
Unlike fully computational approaches, our platform is designed from the bottom-up to seamlessly integrate experimental insights and artificial intelligence.
Octavia relies on several enabling technologies like protein display systems, deep mutational scanning, single-cell sorting and deep sequencing.